Susan E Clare

US Patent:

20030129485, Jul 10, 2003

Filed:

Jan 2, 2003

Appl. No.:

10/336455

Inventors:

Michael Guidi - West Seneca NY, US
Hong Gan - East Amherst NY, US
Mark Roy - Buffalo NY, US
Susan Clare - East Amherst NY, US

International Classification:

H01M004/02
H01M004/58
H01M004/50
H01M004/52
H01M004/66
H01M004/48
H01M004/54
H01M010/40
H01M010/44

US Classification:

429/128000, 429/219000, 429/231500, 429/221000, 429/220000, 429/231300, 429/223000, 429/224000, 429/231100, 429/231700, 429/245000, 429/328000, 429/329000, 429/330000, 429/333000, 429/332000, 429/231950, 429/052000

Abstract:

A new cathode design has a first cathode active material of a relatively low energy density but of a relatively high rate capability contacted to the outer sides of first and second cathode current collectors and a second cathode active material having a relatively high energy density but of a relatively low rate capability in contact with the inner sides of the current collectors. The second cathode active material has a greater peripheral extend than the current collectors and the opposed layers of the first cathode active material between which it is sandwiched. This construction helps prevent delamination by promoting improved contact of the respective active materials to the current collectors. The present cathode design is useful for powering an implantable medical device requiring a high rate discharge application.

US Patent:

20090061461, Mar 5, 2009

Filed:

Sep 26, 2006

Appl. No.:

11/992699

Inventors:

Michael Cahill - Loerzweiler, DE
Andre Schrattenholz - Mainz, DE
Raffael Kurek - Dieburg, DE
Diethelm Wallwiener - Tubingen, DE
Hans Neubauer - Tubingen, DE
Susan Clare - Chicago IL, US

International Classification:

G01N 33/567

US Classification:

435 721

Abstract:

A method of diagnosing diseases associated with aberrant biological phenotypes including contacting a sample to be tested with at least one isoform of membrane associated progesterone receptor component 1 (mPR) as a diagnostic marker, and determining or estimating the degree of phosphorylation of the membrane associated progresterone receptor component 1 (mPR).

US Patent:

20140162903, Jun 12, 2014

Filed:

Oct 31, 2013

Appl. No.:

14/068923

Inventors:

- West Lafayette IN, US
Siwei Wei - West Lafayette IN, US
Susan E. Clare - Chicago IL, US

Assignee:

Purdue Research Foundation - West Lafayette IN

International Classification:

G01N 33/49

US Classification:

506 12, 506 15

Abstract:

The present disclosure relates to a panel of metabolite species that is useful for forecasting the outcome of preoperative chemotherapy for the treatment of breast cancer, including methods for identifying and using such metabolite species that can be measured in biological samples taken before treatment. In preferred embodiments, a method of forecasting a treatment outcome before subjecting a breast cancer patient to preoperative chemotherapy is disclosed that includes measuring the concentration of at least one metabolite species in a sample of a biofluid taken from the breast cancer patient before preoperative chemotherapy treatment.

Address:

175 E Delaware Pl APT 5321, Chicago, IL 60611

VIN:

4T1BB46K37U001760

Make:

TOYOTA

Model:

CAMRY HYBRID

Year:

2007